Log in
Enquire now
Slayback Pharma

Slayback Pharma

Slayback Pharma is a Princeton, New Jersey-based company founded in 2011 by Ajay K Singh.

OverviewStructured DataIssuesContributors

Contents

slayback-pharma.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Engineering
Engineering
Biomedical engineering
Biomedical engineering
Manufacturing
Manufacturing
Location
Princeton, New Jersey
Princeton, New Jersey
CEO
Ajay K Singh
Ajay K Singh
Founder
Ajay K Singh
Ajay K Singh
Legal Name
Slayback Pharma LLC
Number of Employees (Ranges)
51 – 200
Email Address
contact@slayback-pharma.com
Phone Number
+16099453443
Full Address
301 Carnegie Center, Suite 303, Princeton, NJ 08540
Investors
KKR
KKR
Everstone Group
Everstone Group
Founded Date
January 1, 2011
Total Funding Amount (USD)
110,000,000
Latest Funding Round Date
January 6, 2020
Competitors
Maia Pharmaceuticals
Maia Pharmaceuticals
Silk Therapeutics, Inc.
Silk Therapeutics, Inc.
Reata Pharmaceuticals
Reata Pharmaceuticals
Latest Funding Type
Private equity
Private equity
Patents Assigned (Count)
1
Country
United States
United States

Other attributes

Company Operating Status
Active
Latest Funding Round Amount (USD)
50,000,000
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Slayback Pharma

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.